Survival Following Surgical Aortic Valve Replacement in Low-Risk Patients: A Contemporary Trial Benchmark

To create a benchmark for the use of TAVR for aortic stenosis treatment in low-risk patients, this study evaluated outcomes of similar patients undergoing SAVR. The STS database was used to isolate low-risk SAVR patients from 2011–2019. Results revealed that when STS predicted risk of mortality (PROM) was below 1 percent or the patient age was below seventy-five years, the eight-year survival rate after SAVR was 95 percent. The authors concluded that the survival rate following SAVR remains excellent, and that this data can be used in the balanced interpretation of further trials comparing SAVR and TAVR.